Travere Therapeutics (TVTX) Cash from Operations Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 158.60% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 4.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.33% |
| Dec 31, 2025 | 314.65% |
| Sep 30, 2025 | 133.68% |
| Jun 30, 2025 | 112.35% |
| Mar 31, 2025 | 64.51% |
| Dec 31, 2024 | 56.09% |
| Sep 30, 2024 | 61.56% |
| Jun 30, 2024 | 22.06% |
| Mar 31, 2024 | -20.53% |
| Dec 31, 2023 | 16.08% |
| Sep 30, 2023 | -20.16% |
| Jun 30, 2023 | -40.64% |
| Mar 31, 2023 | -78.32% |
| Dec 31, 2022 | 13.16% |
| Sep 30, 2022 | -386.98% |
| Jun 30, 2022 | -666.59% |
| Mar 31, 2022 | -108.96% |
| Dec 31, 2021 | -536.79% |
| Sep 30, 2021 | 376.07% |
| Jun 30, 2021 | 200.67% |
| Mar 31, 2021 | 9.20% |
| Dec 31, 2020 | -208.77% |
| Sep 30, 2020 | 147.69% |
| Jun 30, 2020 | 66.23% |
| Mar 31, 2020 | -42.28% |
| Dec 31, 2019 | -26.00% |
| Sep 30, 2019 | -262.17% |
| Jun 30, 2019 | -592.36% |
| Mar 31, 2019 | -39.08% |
| Dec 31, 2018 | -317.45% |
| Sep 30, 2018 | -162.91% |
| Jun 30, 2018 | -150.49% |
| Mar 31, 2018 | -332.46% |
| Dec 31, 2017 | 89.94% |
| Sep 30, 2017 | 33.90% |
| Jun 30, 2017 | 36.99% |
| Mar 31, 2017 | 4.49% |
| Dec 31, 2016 | -139.10% |
| Sep 30, 2016 | 526.39% |
| Jun 30, 2016 | -50.24% |
| Mar 31, 2016 | 45.91% |
| Dec 31, 2015 | 60.95% |
| Sep 30, 2015 | 104.77% |
| Jun 30, 2015 | 170.03% |
| Mar 31, 2015 | 32.75% |
| Dec 31, 2014 | -8.32% |
| Mar 31, 2014 | -114.16% |